Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
First Opinion
Biotech
Coronavirus
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

University of California squares off against major publisher, with big stakes for access to research

  • Rebecca Robbins

By Rebecca Robbins Dec. 19, 2018

Reprints
Berkeley and Oakland
The University of California campus in Berkeley. Eric Risberg/AP

This story first appeared in “Go West,” STAT’s weekly newsletter about West Coast life sciences, health care, and biotech. Sign up here to receive it in your inbox. 

SAN FRANCISCO — There’s a high-stakes fight in California that could shape the way that academic research gets read and published far beyond the West Coast.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Tags

Surgeons often take a fifth of the lungs to…
Surgeons often take a fifth of the lungs to remove a small tumor. There may be…
Medicare is using one of its biggest hammers to…
Medicare is using one of its biggest hammers to try to fix the dialysis system: how…
Push to double up on Covid booster and flu…
Push to double up on Covid booster and flu shot may have a downside, experts caution
Shakeup with Optum’s health data licensing sparks an outcry…
Shakeup with Optum’s health data licensing sparks an outcry among scientists
Bayer’s venture arm ramps up, seeking to invest $1.3…
Bayer’s venture arm ramps up, seeking to invest $1.3 billion
Researchers show they can quickly turn CAR-T cells on…
Researchers show they can quickly turn CAR-T cells on and off, raising hopes for safer cancer…

Recommended Stories